相关实验视频

Updated: Jul 5, 2025

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

准NAT10/NPM1轴取消PD-L1表达,并改善对免疫检查点阻塞疗法的反应

Ge Qin^1,2,3,4, Fan Bai^1,2,3,4, Huabin Hu^1,2,3,4

¹Department of General Surgery, The Sixth Affiliated Hospital, Sun Yat-Sen University, Yuan Cun Er Rd No. 26, Guangzhou, 510655, People's Republic of China.

Molecular medicine (Cambridge, Mass.)

|January 19, 2024

概括

NAT10/NPM1轴增强了癌症中的PD-L1表达. 用雷莫德林抑制NAT10并将其与抗CTLA-4疗法结合,显示出癌症治疗的前景.

科学领域:

免疫学免疫学免疫学
癌症生物学癌症生物学
分子瘤学分子瘤学

背景情况:

编程细胞死亡蛋白1 (PD-1) 和它的连接体 (PD-L1) 是癌症中的关键免疫检查点抑制剂.
之前的研究确定了核蛋白1 (NPM1) 作为PD-L1的转录调节器,但机制尚不清楚.

研究的目的:

阐明NPM1在PD-L1转录中的调节机制.
调查NPM1乙化在PD-L1表达中的作用.
评估针对NAT10/NPM1轴的治疗潜力.

主要方法:

利用人类癌细胞系研究NPM1在PD-L1转录中的作用.
采用共免疫沉和质谱法来识别NAT10作为NPM1乙转移酶.
在动物模型中评估了联合NAT10抑制剂 (Remodelin) 和抗CTLA-4疗法.

主要成果:

通过NAT10对NPM1的乙化增强了PD-L1在各种癌症中的转录和表达.
雷莫德林治疗降低了NPM1乙化和PD-L1水平.
组合雷莫德林和抗CTLA-4疗法在体内显示出更高的疗效.
瘤中NAT10表达与PD-L1正相关,表明预后不佳.

结论:

NAT10/NPM1轴代表了各种恶性瘤的重要治疗标.
针对这一轴,为癌症免疫治疗提供了一种新的策略.

关键词:

免疫治疗是一种免疫疗法.在 NAT10 中,NAT10 包含了NAT10.在 NPM1 中,在PD-L1中.雷莫德林 (Remodelin) 是一种药物.

更多相关视频

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Monitoring PD-1-Blocking Antibodies Bound to T Cells Derived from a Drop of Peripheral Blood

Published on: February 5, 2020

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.